The Dieli-Conwright Laboratory fosters and conducts innovative research to develop and implement novel lifestyle (e.g., exercise, diet) intervention approaches to prevent cancer risk, recurrence, and mortality in the support of healthy living for those affected by cancer.
Over recent years, exercise has emerged as an important factor to enhance cancer survivorship outcomes, including research being conducted across a broad range of disciplines from all over the world. This increased interest has lead to significant advances in knowledge regarding the efficacy and application of exercise prior to and following a cancer diagnosis, a research specialization now termed exercise oncology.
The interest in and scope of exercise oncology research is projected to further increase over time as we continue to move toward patient-centered care. Thus it is increasingly important to drive the field forward to assess the potential benefits exercise may have on a wide range of cancer-related outcomes ranging from tumor biology to metabolic disruptions to treatment toxicity and efficacy. We utilize a collaborative effort from leading scientists across the world to advance exercise oncology research and its related entities.